Acthar® Gel (repository corticotropin injection) is a prescription medicine used for:
- The reduction of proteinuria in people with nephrotic syndrome of the idiopathic type (unknown origin) without uremia (accumulation of urea in the blood due to malfunctioning kidneys) or that due to lupus erythematosus (lupus)
- Treatment of infantile spasms in infants and children under 2 years of age
- Treatment for adults with acute relapses or flares of multiple sclerosis (MS). Studies have shown Acthar Gel to be effective in speeding recovery from an MS relapse. However, there is no evidence that Acthar affects the ultimate outcome or natural history of the disease
- Treatment of severe acute and chronic allergic and inflammatory conditions affecting different parts of the eye. This can include the front part of the eye such as the cornea and iris, or the back part of the eye such as the optic nerve and retina
- Treatment for people with symptoms of sarcoidosis
- Treatment for flares or on a regular basis (maintenance) in people with systemic lupus erythematosus (lupus)
- Treatment for flares or on a regular basis (maintenance) in people with dermatomyositis or polymyositis (DM-PM)
- Adjunctive therapy for short-term administration (to tide patients over an acute episode or exacerbation) in: psoriatic arthritis (PsA); rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy); ankylosing spondylitis